Europe Liposome Drug Delivery Market to Grow at a CAGR of 8.2% to reach US$ 2,160.12 Million from 2020 to 2027

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Liposome Drug Delivery Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Liposome Drug Delivery Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Liposome Drug Delivery in Cancer Therapy

5.2 Market Opportunities

5.2.1 Research & Development (R&D) Activities

5.3 Future Trends

5.3.1 Fast regulatory approval

5.4 Impact of Drivers and Restraints

6. Europe Liposome Drug Delivery Market Regional Analysis

6.1 Europe Liposome Drug Delivery Market Overview

6.2 Europe Liposome Drug Delivery Market Revenue 2017-2027 (US$ Million)

6.3 Europe Liposome Drug Delivery Market Forecast Analysis

7. Europe Liposome Drug Delivery Market Analysis – by Product

7.1 Liposomal Doxorubicin

7.1.1 Overview
7.1.2 Liposomal Doxorubicin: Europe Liposome Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Liposomal Paclitaxel

7.2.1 Overview
7.2.2 Liposomal Paclitaxel: Europe Liposome Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Liposomal Amphotericin B

7.3.1 Overview
7.3.2 Liposomal Amphotericin B: Europe Liposome Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Liposome Drug Delivery Market Analysis – by Technology

8.1 Stealth Liposome Technology

8.1.1 Overview
8.1.2 Stealth Liposome Technology: Europe Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Non-PEGylated Liposome Technology

8.2.1 Overview
8.2.2 Non-PEGylated Liposome Technology: Europe Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.3 DepoFoam Liposome Technology

8.3.1 Overview
8.3.2 DepoFoam Liposome Technology: Europe Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9. Europe Liposome Drug Delivery Market Analysis – by Application

9.1 Fungal Diseases

9.1.1 Overview
9.1.2 DepoFoam Liposome Technology: Europe Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.2 Pain Management

9.2.1 Overview
9.2.2 DepoFoam Liposome Technology: Europe Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.3 Cancer Therapy

9.3.1 Overview
9.3.2 DepoFoam Liposome Technology: Europe Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.4 Viral Vaccines

9.4.1 Overview
9.4.2 DepoFoam Liposome Technology: Europe Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.5 Photodynamic Therapy

9.5.1 Overview
9.5.2 DepoFoam Liposome Technology: Europe Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10. Europe Liposome Drug Delivery Market – Europe Analysis

10.1 Europe

10.1.1 Europe Liposome Drug Delivery Market Breakdown, by Key Country, 2020 and 2027 (%)
10.1.1.1 Europe Liposome Drug Delivery Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.1.1 UK: Europe Liposome Drug Delivery Market Breakdown, by Product
10.1.1.1.2 UK: Europe Liposome Drug Delivery Market Breakdown, by Technology
10.1.1.1.3 UK: Europe Liposome Drug Delivery Market Breakdown, by Application

10.1.1.2 Germany: Europe Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.2.1 Germany: Europe Liposome Drug Delivery Market Breakdown, by Product
10.1.1.2.2 Germany: Europe Liposome Drug Delivery Market Breakdown, by Technology
10.1.1.2.3 Germany: Europe Liposome Drug Delivery Market Breakdown, by Application

10.1.1.3 France: Europe Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.3.1 France: Europe Liposome Drug Delivery Market Breakdown, by Product
10.1.1.3.2 France: Europe Liposome Drug Delivery Market Breakdown, by Technology
10.1.1.3.3 France: Europe Liposome Drug Delivery Market Breakdown, by Application

10.1.1.4 Russia: Europe Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.4.1 Russia: Europe Liposome Drug Delivery Market Breakdown, by Product
10.1.1.4.2 Russia: Europe Liposome Drug Delivery Market Breakdown, by Technology
10.1.1.4.3 Russia: Europe Liposome Drug Delivery Market Breakdown, by Application

10.1.1.5 Italy: Europe Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.5.1 Italy: Europe Liposome Drug Delivery Market Breakdown, by Product
10.1.1.5.2 Italy: Europe Liposome Drug Delivery Market Breakdown, by Technology
10.1.1.5.3 Italy: Europe Liposome Drug Delivery Market Breakdown, by Application

10.1.1.6 Rest of Europe: Europe Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Liposome Drug Delivery Market Breakdown, by Product
10.1.1.6.2 Rest of Europe: Europe Liposome Drug Delivery Market Breakdown, by Technology
10.1.1.6.3 Rest of Europe: Europe Liposome Drug Delivery Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Liposome Drug Delivery Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Takeda Pharmaceutical Company Limited

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Novartis AG

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Luye Pharma Group

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Johnson & Johnson Services, Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Ipsen Pharma

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Gilead Sciences, Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Celsion, Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Astellas Pharma Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights